Literature DB >> 10617911

Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.

N Kitaichi1, A Matsuda, S Kotake, K Namba, Y Tagawa, Y Sasamoto, K Ogasawara, K Iwabuchi, K Onoé, H Matsuda, J Nishihira.   

Abstract

PURPOSE: The role of macrophage migration inhibitory factor (MIF) in the regulation of ocular autoimmune disease was studied in experimental autoimmune uveoretinitis (EAU) in rats following immunization with a retinal antigen (Ag), interphotoreceptor retinoid-binding protein (IRBP).
METHODS: LEW rats were immunized with a single injection of IRBP derived peptide, R16(ADGSSWEGVGVVPDV). A neutralizing monoclonal antibody (mAb, IgM) to MIF was injected intraperitoneally every second day from day 0 to day 6 (group A), or from day 8 to day 14 (group B). Control rats were treated with unrelated mouse IgM or PBS. T cell proliferative responses were measured 12 days after immunization. The occurrence and severity of EAU were observed and compared among experimental and control groups.
RESULTS: T cell proliferative responses against R16 were inhibited in rats treated with anti-MIF mAb compared with the control rats. The development of EAU was delayed in the rats of group A in comparison with those of group B and the control group. The mean histological EAU score on day 18 in group A was 1.11 +/- 0. 11 and significantly lower than those of the group B (1.29 +/- 0.19) and the control (1.67 +/- 0.19).
CONCLUSIONS: The present result suggests that MIF plays an important role in induction of EAU.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617911

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis.

Authors:  N Kitaichi; S Kotake; Y Mizue; H Matsuda; K Onoé; J Nishihira
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor.

Authors:  Gillian S Ashcroft; Stuart J Mills; KeJian Lei; Linda Gibbons; Moon-Jin Jeong; Marisu Taniguchi; Matthew Burow; Michael A Horan; Sharon M Wahl; Toshinori Nakayama
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

3.  Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.

Authors:  H Yang; S Zheng; Y Mao; Z Chen; C Zheng; H Li; C Sumners; Q Li; P Yang; B Lei
Journal:  Clin Exp Immunol       Date:  2015-11-17       Impact factor: 4.330

Review 4.  Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets.

Authors:  Jeongtae Kim; Jiyoon Chun; Meejung Ahn; Kyungsook Jung; Changjong Moon; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2022-03-31

Review 5.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.